AMENDED SETTLEMENT ALLOCATION AGREEMENTSettlement Allocation Agreement • April 5th, 2022 • Biofrontera Inc. • Pharmaceutical preparations • Massachusetts
THIS AMENDED SETTLEMENT ALLOCATION AGREEMENT (the “Agreement”) is made this 31st day of March, 2022, between Biofrontera Inc., a Delaware Corporation (“Inc”), and Biofrontera Bioscience GmbH, Biofrontera Pharma GmbH, Biofrontera Development GmbH, Biofrontera Neuroscience GmbH, each a limited liability company organized under the laws of Germany, and Biofrontera AG (collectively, “AG”), a corporation organized and existing under the laws of Germany. Inc and AG may be individually referred to as a “Party” or collectively as the “Parties.”
AMENDMENT TO EMPLOYMENT AGREEMENTEmployment Agreement • April 5th, 2022 • Biofrontera Inc. • Pharmaceutical preparations
This Amendment to Employment Agreement (the “Amendment”) is made effective as of April 1, 2022 (the “Effective Date of this Amendment”), by and between Biofrontera, Inc, a Delaware corporation (the “Company”) having its registered office at 120 Presidential Way, Suite 330, Woburn, MA 01801 and Erica Monaco (the “Executive”), currently employed as Chief Executive Officer for Biofrontera Inc.
